Platform Features
220 Riverbend Road Athens GA 30602 US

Pathens Incorporated

Suggestions or opinions?

Email you thoughts, or come see us in person.

Developing vaccines for the world

Lead Technology

If you are interested in partnering with us to target specific diseases or for more information, please contact us at:

The vaccine platform has unique features:

  • Large payload to target multiple diseases or multiple antigens from a single pathogen
  • Built-in adjuvant
  • Intranasal vaccine delivery is needle-free
  • Natural temperature restriction 

Pathens Incorporated is an emerging biotechnology company founded by Infectious Diseases faculty at the University of Georgia. The mission of the company is to translate host/pathogen laboratory research into vaccines and diagnostics against infectious diseases and cancer.

Pathens has developed a proprietary vaccine platform technology that can be used to target any number of diseases.

Contact Us